Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riverstone HoldingsSGX:AP4 -0.63%66 EV-to-EBIT is 12.14 as of Sep. 08, 2026, which is 7% below its 10-year median of 13.09. GuruFocus rates SGX:AP4 with a GF Score™ of 66/100 and a GF Value™ of S$0.85 (Fairly Valued). The stock has 6 warning signs investors should review. Among 475 Medical Devices & Instruments companies, Riverstone Holdings ranks better than 68.42% on this metric.
The historical rank and industry rank for Riverstone Holdings's EV-to-EBIT or its related term are showing as below:
SGX:AP4'
s EV-to-EBIT Range Over the Past 10 Years
Min: 1.88 Med: 13.09 Max: 84.47
Current: 12.15
During the past 13 years, the highest EV-to-EBIT of Riverstone Holdings was 84.47. The lowest was 1.88. And the median was 13.09.
SGX:AP4's EV-to-EBIT is ranked better than 68.42% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 18.49
vs SGX:AP4: 12.15
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Riverstone Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was S$1,085.1 Mil.
Riverstone Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$81.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Riverstone Holdings EV-to-EBIT Related Terms
Riverstone Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Riverstone Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's EV-to-EBIT falls into.
Riverstone Holdings's current Enterprise Value is S$983.5 Mil.
Riverstone Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$81.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Riverstone Holdings (SGX:AP4) has a EV-to-EBIT of 12.14 as of Sep. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Riverstone Holdings and its competitors. This is near median its historical median of 13.09. Over the past decade, Riverstone Holdings' EV-to-EBIT has ranged from 1.88 to 84.47. According to the industry distribution chart, Riverstone Holdings ranks #150 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 31.6%.
Is Riverstone Holdings' EV-to-EBIT too high?
Riverstone Holdings' current EV-to-EBIT of 12.14 is near median its 10-year median of 13.09. Over the past 10 years, this metric has ranged from a low of 1.88 to a high of 84.47. The Medical Devices & Instruments industry median EV-to-EBIT is 18.49. Riverstone Holdings' value of 12.14 is 34.3% below this industry median. Based on the distribution chart, Riverstone Holdings ranks #150 out of 475 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Riverstone Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #150 out of 475 companies for EV-to-EBIT. This puts Riverstone Holdings in the upper half of its industry. The industry median EV-to-EBIT is 18.49. Riverstone Holdings' value of 12.14 is 34.3% below this benchmark. Historically, Riverstone Holdings' own EV-to-EBIT has ranged from 1.88 to 84.47 over the past decade. While the company's 10-year median is 13.09 vs. the industry median of 18.49, Riverstone Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.49, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current EV-to-EBIT of 12.14 is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Riverstone Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current EV-to-EBIT is 12.14, which is near median its own 10-year median of 13.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.85, compared to a current price of S$0.79 — trading 7.6% below its estimated fair value. The current EV-to-EBIT is 12.14, which is near median its 10-year median of 13.09 and 34.3% below the Medical Devices & Instruments industry median of 18.49. Riverstone Holdings' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current EV-to-EBIT is 12.14 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued.
The current stock price of S$0.79 is trading 7.6% below its estimated GF Value™ of S$0.85.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
EV-to-EBIT: 12.14 (near median its 10-year median of 13.09)
GF Value™: S$0.85 vs. price of S$0.79 (7.6% below fair value)
Industry Position: 34.3% below the Medical Devices & Instruments median (#150 of 475)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
66GF Score
Get the complete analysis for SGX:AP4
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
